Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
21
SRTS Quote, Financials, Valuation and Earnings
Last price:
$4.14
Seasonality move
:
-1.65%
Day range:
$3.86 - $4.22
52-week range:
$3.03 - $5.92
Dividend yield:
0%
P/E ratio:
34.65x
P/S ratio:
2.41x
P/B ratio:
1.39x
Volume:
14.9K
Avg. volume:
65.5K
1-year change:
-18.29%
Market cap:
$66.7M
Revenue:
$27.5M
EPS (TTM):
-$0.47
Analysts' Opinion
-
Consensus RatingSensus Healthcare, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $6.88, Sensus Healthcare, Inc. has an estimated upside of 67.28% from its current price of $4.11.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $6.00 representing 100% downside risk from its current price of $4.11.
Fair Value
-
According to the consensus of 3 analysts, Sensus Healthcare, Inc. has 67.28% upside to fair value with a price target of $6.88 per share.
SRTS vs. S&P 500
-
Over the past 5 trading days, Sensus Healthcare, Inc. has underperformed the S&P 500 by -0.84% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Sensus Healthcare, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Sensus Healthcare, Inc. revenues have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Sensus Healthcare, Inc. reported revenues of $4.9M.
Earnings Growth
-
Sensus Healthcare, Inc. earnings have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter Sensus Healthcare, Inc. reported earnings per share of -$0.19.
Enterprise value:
46M
EV / Invested capital:
--
Price / LTM sales:
2.41x
EV / EBIT:
14.83x
EV / Revenue:
1.68x
PEG ratio (5yr expected):
0.01x
EV / Free cash flow:
138.70x
Price / Operating cash flow:
199.23x
Enterprise value / EBITDA:
12.57x
Gross Profit (TTM):
$11.9M
Return On Assets:
-13.19%
Net Income Margin (TTM):
-28.09%
Return On Equity:
-14.83%
Return On Invested Capital:
-14.67%
Operating Margin:
-63.76%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Income Statement | ||||||
| Revenue | $24.4M | $41.8M | $27.5M | $13.1M | $4.9M | |
| Gross Profit | $14.1M | $24.4M | $11.9M | $7.1M | $1.9M | |
| Operating Income | -$384K | $8.1M | -$10.3M | $1.7M | -$3.1M | |
| EBITDA | -$13K | $8.5M | -$9.7M | $1.9M | -$3M | |
| Diluted EPS | $0.03 | $0.41 | -$0.47 | $0.09 | -$0.19 | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $31.2M | $53.2M | $49.5M | $56.7M | $45.9M | |
| Total Assets | $32.2M | $56.7M | $53.7M | $62.2M | $53.1M | |
| Current Liabilities | $6M | $7.7M | $4.2M | $5.9M | $4.7M | |
| Total Liabilities | $6.2M | $8.7M | $4.9M | $6.4M | $5M | |
| Total Equity | $26M | $48.1M | $48.8M | $55.8M | $48.1M | |
| Total Debt | $51K | $830K | $596K | $398K | $209K | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$2.1M | -$831K | $528K | -$827K | -$2.2M | |
| Cash From Investing | -$187K | -$276K | -$196K | $297K | -$158K | |
| Cash From Financing | -$40K | $15K | -$305K | $28K | -$5K | |
| Free Cash Flow | -$2.4M | -$1.1M | $332K | -$530K | -$2.4M | |
SRTS
Sector
Market Cap
$66.7M
$23.9M
Price % of 52-Week High
69.43%
47.44%
Dividend Yield
0%
0%
Shareholder Yield
0.51%
-1.9%
1-Year Price Total Return
-18.29%
-18.29%
Beta (5-Year)
1.276
0.513
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$4.03
200-day SMA
Buy
Level
$4.05
Bollinger Bands (100)
Sell
Level
3.8 - 4.72
Chaikin Money Flow
Buy
Level
24.5K
20-day SMA
Buy
Level
$4.04
Relative Strength Index (RSI14)
Buy
Level
50.08
ADX Line
Buy
Level
25.4
Williams %R
Neutral
Level
-55.6962
50-day SMA
Sell
Level
$4.35
MACD (12, 26)
Buy
Level
1.07
25-day Aroon Oscillator
Sell
Level
-76
On Balance Volume
Neutral
Level
95.4K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (8.8967)
Buy
CA Score
(Annual)
Level (0.7603)
Buy
Beneish M-Score
(Annual)
Level (-3.5883)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (0.9667)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Sensus Healthcare, Inc. is a medical device company, which engages in the provision of treatment for both oncological and non-oncological skin conditions. The company was founded by Joseph C. Sardano, Richard Golin, Kalman Fishman, and Stephen Cohen on May 7, 2010 and is headquartered in Boca Raton, FL.
Stock Forecast FAQ
In the current month, SRTS has received 3 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SRTS average analyst price target in the past 3 months is $6.88.
-
Where Will Sensus Healthcare, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Sensus Healthcare, Inc. share price will rise to $6.88 per share over the next 12 months.
-
What Do Analysts Say About Sensus Healthcare, Inc.?
Analysts are divided on their view about Sensus Healthcare, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Sensus Healthcare, Inc. is a Sell and believe this share price will drop from its current level to $6.00.
-
What Is Sensus Healthcare, Inc.'s Price Target?
The price target for Sensus Healthcare, Inc. over the next 1-year time period is forecast to be $6.88 according to 3 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is SRTS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Sensus Healthcare, Inc. is a Buy. 3 of 3 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of SRTS?
You can purchase shares of Sensus Healthcare, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Sensus Healthcare, Inc. shares.
-
What Is The Sensus Healthcare, Inc. Share Price Today?
Sensus Healthcare, Inc. was last trading at $4.14 per share. This represents the most recent stock quote for Sensus Healthcare, Inc.. Yesterday, Sensus Healthcare, Inc. closed at $4.11 per share.
-
How To Buy Sensus Healthcare, Inc. Stock Online?
In order to purchase Sensus Healthcare, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get SRTS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SRTS
Sector
P/E ratio
34.65x
21.37x
PEG ratio
0.01x
-0.01x
P/B ratio
1.39x
1.72x
Price / LTM sales
2.41x
1.44x
Growth Metrics
SRTS
Sector
Revenue growth
-62.2%
3.44%
Earnings growth
-306.38%
14.97%
Revenue (5-year growth)
23.47%
6.27%
Earnings forecast
-$0.11
-$0.22
Profitability
SRTS
Sector
Profitability FY 2025
$11.9M
$2.4M
Return on invested capital
-14.67%
-33.43%
Return on assets
-13.19%
-29.45%
Return on equity
-14.83%
-40.29%
Earnings Date
Last Earnings Date
Feb
12
Next Earnings Date
May
14
Estimated Next Earnings Date
May
14
Balance Sheet
SRTS
Sector
Total cash
$22.1M
$25.6M
Short term investments
--
$22.7M
Total assets
$53.1M
$70.4M
Long term debt
$209K
$2.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
46
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 36x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 27x
Alerts
Buy
51
AAOI alert for Apr 3
Applied Optoelectronics, Inc. [AAOI] is up 20.3% over the past day.
Buy
59
SBAC alert for Apr 3
SBA Communications Corp. [SBAC] is up 18.96% over the past day.
Buy
55
VSAT alert for Apr 3
ViaSat, Inc. [VSAT] is up 18.73% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
